Dr James A. Roberts BSc, MRes, PhD

Dr James A. Roberts

Department of Biomedical Sciences
Post-doctoral research fellow

Contact details

Address
Robert Aitken Institute for Clinical Research
Department of Biomedical Sciences
College of Medicine and Health
University of Birmingham
B15 2TT

Dr James Roberts is a Post-doctoral research fellow in the Department of Biomedical Sciences based in the College of Medicine and Health. His research interests include oxidative stress in neuro-ophthalmological diseases such as age-related macular degeneration and glaucoma.

Qualifications

  • PhD in Cellular and Molecular Physiology, 2024
  • MRes in Cellular and Molecular Physiology, 2020
  • BSc in Pharmacology, 2019

Biography

Dr James Roberts is a cellular and molecular biologist with a background in cardiovascular toxicity induced by chemotherapeutics and associated protection by antioxidants. He completed his PhD exploring NRF2 molecular mechanisms contributing to the mitigation of doxorubicin-induced cardio-toxicity at the University of Liverpool in 2024. Since achieving a post-doctoral position at the University of Birmingham, Dr Roberts has worked in the neuro-ophthalmology group lead by Associate Professor Lisa Hill and Dr Hannah Botfield. His research focusses on improving drug delivery for sight-threatening ocular diseases including age-related macular degeneration and glaucoma. Furthermore, this research is seeking to explore novel therapeutics for the treatment of ocular and neurodegenerative diseases more widely.

Dr Roberts is also a key member of the biofluids workstream within the pioneering mTBI-PREDICT clinical study, a long-term multicentre study aiming to identify clinical biomarkers to identify risks in those who have suffered mild traumatic brain injury (mTBI).

Research

  • Developing in vitro, ex vivo and in vivo models of ocular diseases including age-related macular degeneration and glaucoma
  • Investigating cellular and molecular mechanisms of ocular diseases including the contribution of oxidative stress
  • Developing new therapies for ocular disease
  • Developing novel methods to deliver drugs into the eye